Patents by Inventor Bo Christer Larsson

Bo Christer Larsson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5872097
    Abstract: Straight or cyclic pentapeptides with receptor affinity to .mu. or .delta. opioid receptors having a primary sequence backbone of Tyr-X-Phe-Leu-Z, Seq. ID Nos. 1, 2, and 3. X and Z can be covalently coupled to provide a heterocyclic structure according to the following conditions:i) when the pentapeptide is straight X is selected from the group consisting of Ser, Gly, Pro, AMCA and D-Ala and Z is selected from the group consisting of Glu, Gln or amino derivatives of Glu or Gln, Seq. ID No. 1, with the proviso that if X is Ser, then Z is Glu or amino derivatives of Glu; andii) where the pentapeptide is cyclic X is selected from the group consisting of D- or L-2,4-diaminobutyric acid, D- or L-lysine, D- or L-ornithine and D or L-cysteine and Z is selected from the group consisting of Gln or Glu or amino derivatives of Gln or Glu, Seq. ID No. 2, and 3, with the proviso that if X is D-or L-Cys, then Z is Cys, Seq. ID No. 3.
    Type: Grant
    Filed: September 7, 1995
    Date of Patent: February 16, 1999
    Assignee: Pharmacia & Upjohn Aktiebolag
    Inventors: Karin Ingeborg Fholenhag, Linda Fryklund, Bo Christer Larsson, Fred Jarl Nyberg, Gertrud Elisabeth Westin-Sjodahl, Ronny Lundin